In a recent video interview, Amy K. Patel, MD, discussed the aftereffects of delayed breast cancer screening due to the COVID-19 pandemic, keys for improving outreach to underserved communities, legislative wins and challenges, and coalition building to educate and encourage women to resume regular breast cancer screening exams.
As we begin to emerge from the shadows of the COVID-19 pandemic, it is clear that radiologists, particularly breast radiologists, are faced with significant challenges. On top of workload issues, they may be communicating a greater number of advanced breast cancer diagnoses due to pandemic-related screening delays.
However, as Amy K. Patel, MD, points out in a recent video interview with Diagnostic Imaging, there are also emerging opportunities to save lives.
Whether it is being an advocate in legislative efforts to improve breast exam coverage, doing more outreach to underserved populations and/or building local coalitions that provide resources and support to patients, these efforts can go a long way toward emphasizing and facilitating a return to regular breast cancer screening, according to Dr. Patel, the medical director of the Breast Care Center at Liberty Hospital in Liberty, Missouri, and an assistant professor of radiology at the University of Missouri-Kansas City (UMKC) School of Medicine
For additional insights from Dr. Patel on breast imaging, watch the video below.
Contrast-Enhanced Mammography and Dense Breasts: What a New Meta-Analysis Reveals
May 1st 2024The 10-study meta-analysis demonstrated that contrast-enhanced mammography has a 95 percent sensitivity rate and an 81 percent specificity rate for diagnosing suspicious lesions in women with dense breasts.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.